Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 11852656)

1.

[Old and new mu-opioids. Mu-selective opioids with a morphinan structure].

Buschmann H, Sundermann B, Maul C.

Pharm Unserer Zeit. 2002;31(1):44-50. Review. German. No abstract available.

PMID:
11852656
2.

2-aminothiazole-derived opioids. Bioisosteric replacement of phenols.

Zhang A, Xiong W, Hilbert JE, DeVita EK, Bidlack JM, Neumeyer JL.

J Med Chem. 2004 Apr 8;47(8):1886-8.

PMID:
15055988
3.

Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.

Mathews JL, Peng X, Xiong W, Zhang A, Negus SS, Neumeyer JL, Bidlack JM.

J Pharmacol Exp Ther. 2005 Nov;315(2):821-7. Epub 2005 Aug 2.

4.

Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.

Yuan Y, Elbegdorj O, Chen J, Akubathini SK, Zhang F, Stevens DL, Beletskaya IO, Scoggins KL, Zhang Z, Gerk PM, Selley DE, Akbarali HI, Dewey WL, Zhang Y.

J Med Chem. 2012 Nov 26;55(22):10118-29. doi: 10.1021/jm301247n. Epub 2012 Nov 9.

5.

Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.

Neumeyer JL, Zhang A, Xiong W, Gu XH, Hilbert JE, Knapp BI, Negus SS, Mello NK, Bidlack JM.

J Med Chem. 2003 Nov 20;46(24):5162-70.

PMID:
14613319
6.

Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.

Li F, Yin C, Chen J, Liu J, Xie X, Zhang A.

Chem Biol Drug Des. 2009 Oct;74(4):335-42. doi: 10.1111/j.1747-0285.2009.00849.x. Epub 2009 Aug 19.

PMID:
19691470
7.

Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.

Spetea M, Schüllner F, Moisa RC, Berzetei-Gurske IP, Schraml B, Dörfler C, Aceto MD, Harris LS, Coop A, Schmidhammer H.

J Med Chem. 2004 Jun 3;47(12):3242-7.

PMID:
15163203
8.

Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE.

J Pharmacol Exp Ther. 2004 Feb;308(2):547-54. Epub 2003 Nov 4.

9.

Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S.

Nature. 2012 Mar 21;485(7398):321-6. doi: 10.1038/nature10954.

10.

Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.

Nemoto T, Fujii H, Narita M, Miyoshi K, Nakamura A, Suzuki T, Nagase H.

Bioorg Med Chem. 2008 Apr 15;16(8):4304-12. doi: 10.1016/j.bmc.2008.02.082. Epub 2008 Feb 29.

PMID:
18337104
11.
12.

Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.

Ananthan S, Khare NK, Saini SK, Davis P, Dersch CM, Porreca F, Rothman RB.

Bioorg Med Chem. 2003 Sep 1;11(18):4143-54.

PMID:
12927876
13.

Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones.

Nieland NP, Moynihan HA, Carrington S, Broadbear J, Woods JH, Traynor JR, Husbands SM, Lewis JW.

J Med Chem. 2006 Aug 24;49(17):5333-8.

14.

Activation of opioid mu-receptor by sinomenine in cell and mice.

Wang MH, Chang CK, Cheng JH, Wu HT, Li YX, Cheng JT.

Neurosci Lett. 2008 Oct 10;443(3):209-12. doi: 10.1016/j.neulet.2008.07.088. Epub 2008 Aug 3.

PMID:
18692550
15.

Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.

Greiner E, Spetea M, Krassnig R, Schüllner F, Aceto M, Harris LS, Traynor JR, Woods JH, Coop A, Schmidhammer H.

J Med Chem. 2003 Apr 24;46(9):1758-63.

PMID:
12699394
16.

Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.

Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR.

Eur J Pharmacol. 2004 Sep 19;499(1-2):107-16.

PMID:
15363957
17.
18.

Design, chemical synthesis, and biological evaluation of thiosaccharide analogues of morphine- and codeine-6-glucuronide.

MacDougall JM, Zhang XD, Polgar WE, Khroyan TV, Toll L, Cashman JR.

J Med Chem. 2004 Nov 4;47(23):5809-15.

PMID:
15509180
19.

Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists.

Fujii H, Watanabe A, Nemoto T, Narita M, Miyoshi K, Nakamura A, Suzuki T, Nagase H.

Bioorg Med Chem Lett. 2009 Jan 15;19(2):438-41. doi: 10.1016/j.bmcl.2008.11.050. Epub 2008 Nov 18.

PMID:
19042127
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk